Technical Analysis for TVTX - Travere Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 1,2,3 Pullback Bullish | Bullish Swing Setup | 2.70% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 2.70% | |
| NR7 | Range Contraction | 2.70% | |
| Narrow Range Bar | Range Contraction | 2.70% | |
| Inside Day | Range Contraction | 2.70% | |
| BB Squeeze Ended | Range Expansion | 2.70% | |
| Down 3 Days in a Row | Weakness | 2.70% | |
| Down 4 Days in a Row | Weakness | 2.70% | |
| Down 5 Days in a Row | Weakness | 2.70% | |
| Fell Below 20 DMA | Bearish | 0.79% |
| Alert | Time |
|---|---|
| Up 1% | about 21 hours ago |
| 60 Minute Opening Range Breakout | about 21 hours ago |
| Non-ADX 1,2,3,4 Pullback Entry | about 21 hours ago |
| 1,2,3, Pullback Entry | about 21 hours ago |
| Rose Above Previous Day's High | about 21 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/05/2024
At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow.
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical IBD 50 Kidney Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Channelopathies Focal Segmental Glomerulosclerosis Glomerulosclerosis
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Biopharmaceutical IBD 50 Kidney Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Spinal Muscular Atrophy Genetic Genealogy Caregiver Channelopathies Focal Segmental Glomerulosclerosis Glomerulosclerosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 20.33 |
| 52 Week Low | 5.12 |
| Average Volume | 1,944,286 |
| 200-Day Moving Average | 10.11 |
| 50-Day Moving Average | 16.56 |
| 20-Day Moving Average | 18.03 |
| 10-Day Moving Average | 18.27 |
| Average True Range | 1.07 |
| RSI (14) | 52.83 |
| ADX | 35.98 |
| +DI | 24.37 |
| -DI | 17.08 |
| Chandelier Exit (Long, 3 ATRs) | 17.13 |
| Chandelier Exit (Short, 3 ATRs) | 19.97 |
| Upper Bollinger Bands | 19.29 |
| Lower Bollinger Band | 16.76 |
| Percent B (%b) | 0.43 |
| BandWidth | 14.00 |
| MACD Line | 0.39 |
| MACD Signal Line | 0.62 |
| MACD Histogram | -0.2328 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 19.09 | ||||
| Resistance 3 (R3) | 18.96 | 18.41 | 18.89 | ||
| Resistance 2 (R2) | 18.41 | 18.10 | 18.48 | 18.82 | |
| Resistance 1 (R1) | 18.14 | 17.91 | 18.28 | 18.27 | 18.75 |
| Pivot Point | 17.59 | 17.59 | 17.66 | 17.66 | 17.59 |
| Support 1 (S1) | 17.32 | 17.28 | 17.46 | 17.45 | 16.97 |
| Support 2 (S2) | 16.77 | 17.09 | 16.84 | 16.90 | |
| Support 3 (S3) | 16.50 | 16.77 | 16.84 | ||
| Support 4 (S4) | 16.63 |
